Not all CBD is created equal, but in many cases it has been viewed as such up till now. This could change if the call by the European Industrial Hemp Association for “proper regulation of CBD” is heeded. The body seeks to have different classes of CBD introduced. It says this will boost the hemp industry by broadening the usage of CBD in the marketplace. In addition, it will be more accessible to the public.
Currently, the different levels of CBD in various products, and in different sectors of the marketplace, are not taken into account. Legality, and therefore the permission to use cannabidiol, is based purely on the fact that it is CBD, and not on how much of it is being used.
Dividing CBD into categories
The EIHA said in a position paper that only a “tenuous patchwork” of regulations controls CBD in the European Union. It has proposed a new standardised regulation system which would both protect consumers, and help the burgeoning hemp industry in Europe. The idea behind the system would be to create three classifications based on the amount of CBD involved. Each category could then be assigned to different areas of the marketplace. These different levels would then also determine the amount of control required on the distribution of the various products involved.
Broadening the usage of CBD
The EIHA is hoping this will make it easier with regard to broadening the usage of CBD by extending the industry’s the scope in the marketplace. It also hopes this might improve the chances of member states allowing the usage of hemp CBD in other sectors, besides medicine.
At present, England is one of the EIHA member states which only recognises CBD as a medicinal product. However, cannabidiol has a far wider range of usages in over-the-counter food supplements, as well as in food products, cosmetics, and other areas. Categorizing CBD according to the amount used, the EIHA believes, might encourage these states to view hemp and CBD as a safe ingredient in foods and cosmetics, so broadening the usage of CBD.
The way the EIHA sees categories working
The Hemp Association suggests CBD be classified into three separate categories for different purposes and requiring different control. The High Level, classified as medicinal, would involve the use of high doses of 200mg or more a day. At the Medium Level (20 to 200mg a day) CBD should be viewed as an over-the-counter food supplement or herbal remedy available without prescription in health stores, or pharmacies. Where the intake would be less than 20mg of CBD per day, the Lowest Level, the EIHA suggests that CBD should be considered suitable for unrestricted use in food products.
The EIHA has admitted that CBD containing hemp extracts might contain the psychoactive cannabinoid THC. It suggests a different regulatory approach here. However, the body says it is vehemently opposed to the idea of CBD being restricted to being a prescription-only drug.